San Diego, CA, United States of America

Saskia Theodora Cornelia Neuteboom



Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • La Jolla, CA (US) (2009)
  • San Diego, CA (US) (2011 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Saskia Theodora Cornelia Neuteboom

Introduction: Saskia Theodora Cornelia Neuteboom is a renowned inventor based in San Diego, California. With an impressive portfolio of five patents to her name, she has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that serve as potential treatments for various diseases.

Latest Patents: Among her latest innovations are two notable patents related to proteasome inhibitors. These patents disclose compounds of Formula (I) that incorporate a sulfonate ester, ester, or ether group. The compounds have applications in pharmaceutical compositions and are designed to treat and ameliorate conditions such as cancer, microbial diseases, and inflammation.

Career Highlights: Neuteboom's career is marked by her tenure at Nereus Pharmaceuticals, Inc., where she played a crucial role in the development of groundbreaking pharmaceutical innovations. Her contributions in this innovative setting have firmly established her reputation as a thought leader in the industry.

Collaborations: Throughout her career, Saskia has worked alongside talented colleagues, including Barbara Christine Potts and Venkat Rami Reddy Macherla. These collaborations have undoubtedly enriched her research and further propelled her inventive pursuits.

Conclusion: Saskia Theodora Cornelia Neuteboom's dedication to innovation and the advancement of pharmaceutical sciences highlights her impact as an inventor. With her continued efforts in creating effective treatments for complex medical conditions, she remains an influential figure in the realm of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…